Pharma Mirror Magazine

Catalent Signs Commercial Supply Agreement with Blueprint Medicines Following FDA Approval of GAVRETOT (pralsetinib)

Catalent Signs Commercial Supply Agreement with Blueprint Medicines Following FDA Approval of GAVRETO™ (pralsetinib)

November 24, 2020

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies,

Pharma Interest

FIP expert group issues advice for pharmacists on COVID-19 tests

November 22, 2020

The Hague — To help pharmacists advise people on COVID-19 tests, the International Pharmaceutical Federation (FIP), has today issued a guidance

Pharmaceutical News·Pharmacy

UCB taps Medisafe in development of digital companion to support patient engagement

November 22, 2020

Medisafe, a leading digital therapeutics company specializing in digital companions, has been selected by UCB to develop branded digital drug

Pharmaceutical News

CPhI & P-MEC China 2020 adapts to customer needs with hybrid pharma event

November 18, 2020

CPhI & P-MEC China returns as a hybrid event in Shanghai (16-18 December 2020), with a physical exhibition running alongside

Pharmaceutical Articles·Pharmacy

Recommended Drugs to Undergo Incineration Process

November 12, 2020

Contributing factors such as the excessive carbon dioxide in the atmosphere and burned fossil fuels wounds the earth at large.

Diseases & Health Tips

Stage 4 Breast Cancer Treatment in Germany

November 4, 2020

To date, breast cancer is one of the most dangerous diseases. Unfortunately, it is not always possible to diagnose it

MORE NEWS

Catalent Signs Commercial Supply Agreement with Blueprint Medicines Following FDA Approval of GAVRETO™ (pralsetinib)

FIP expert group issues advice for pharmacists on COVID-19 tests

UCB taps Medisafe in development of digital companion to support patient engagement

CPhI & P-MEC China 2020 adapts to customer needs with hybrid pharma event

Recommended Drugs to Undergo Incineration Process

Stage 4 Breast Cancer Treatment in Germany